Literature DB >> 34992128

Automated Color-Coding of Lesion Changes in Contrast-Enhanced 3D T1-Weighted Sequences for MRI Follow-up of Brain Metastases.

D Zopfs1, K Laukamp2, R Reimer2, N Grosse Hokamp2, C Kabbasch2, J Borggrefe3, L Pennig2, A C Bunck2, M Schlamann2, S Lennartz2.   

Abstract

BACKGROUND AND
PURPOSE: MR imaging is the technique of choice for follow-up of patients with brain metastases, yet the radiologic assessment is often tedious and error-prone, especially in examinations with multiple metastases or subtle changes. This study aimed to determine whether using automated color-coding improves the radiologic assessment of brain metastases compared with conventional reading.
MATERIALS AND METHODS: One hundred twenty-one pairs of follow-up examinations of patients with brain metastases were assessed. Two radiologists determined the presence of progression, regression, mixed changes, or stable disease between the follow-up examinations and indicated subjective diagnostic certainty regarding their decisions in a conventional reading and a second reading using automated color-coding after an interval of 8 weeks.
RESULTS: The rate of correctly classified diagnoses was higher (91.3%, 221/242, versus 74.0%, 179/242, P < .01) when using automated color-coding, and the median Likert score for diagnostic certainty improved from 2 (interquartile range, 2-3) to 4 (interquartile range, 3-5) (P < .05) compared with the conventional reading. Interrater agreement was excellent (κ = 0.80; 95% CI, 0.71-0.89) with automated color-coding compared with a moderate agreement (κ = 0.46; 95% CI, 0.34-0.58) with the conventional reading approach. When considering the time required for image preprocessing, the overall average time for reading an examination was longer in the automated color-coding approach (91.5 [SD, 23.1] seconds versus 79.4 [SD, 34.7 ] seconds, P < .001).
CONCLUSIONS: Compared with the conventional reading, automated color-coding of lesion changes in follow-up examinations of patients with brain metastases significantly increased the rate of correct diagnoses and resulted in higher diagnostic certainty.
© 2022 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34992128      PMCID: PMC8985679          DOI: 10.3174/ajnr.A7380

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

1.  Improved Detection of New MS Lesions during Follow-Up Using an Automated MR Coregistration-Fusion Method.

Authors:  A Galletto Pregliasco; A Collin; A Guéguen; M A Metten; J Aboab; R Deschamps; O Gout; L Duron; J C Sadik; J Savatovsky; A Lecler
Journal:  AJNR Am J Neuroradiol       Date:  2018-06-07       Impact factor: 3.825

2.  Diagnostic Radiology Resident and Fellow Workloads: A 12-Year Longitudinal Trend Analysis Using National Medicare Aggregate Claims Data.

Authors:  Falgun H Chokshi; Danny R Hughes; Jennifer M Wang; Mark E Mullins; C Matthew Hawkins; Richard Duszak
Journal:  J Am Coll Radiol       Date:  2015-05-09       Impact factor: 5.532

Review 3.  A review of factors influencing radiologists' visual search behaviour.

Authors:  Aarthi Ganesan; Maram Alakhras; Patrick C Brennan; Claudia Mello-Thoms
Journal:  J Med Imaging Radiat Oncol       Date:  2018-09-10       Impact factor: 1.735

Review 4.  Canadian Association of Radiologists White Paper on Artificial Intelligence in Radiology.

Authors:  An Tang; Roger Tam; Alexandre Cadrin-Chênevert; Will Guest; Jaron Chong; Joseph Barfett; Leonid Chepelev; Robyn Cairns; J Ross Mitchell; Mark D Cicero; Manuel Gaudreau Poudrette; Jacob L Jaremko; Caroline Reinhold; Benoit Gallix; Bruce Gray; Raym Geis
Journal:  Can Assoc Radiol J       Date:  2018-04-11       Impact factor: 2.248

5.  Ethics of Artificial Intelligence in Radiology: Summary of the Joint European and North American Multisociety Statement.

Authors:  J Raymond Geis; Adrian P Brady; Carol C Wu; Jack Spencer; Erik Ranschaert; Jacob L Jaremko; Steve G Langer; Andrea Borondy Kitts; Judy Birch; William F Shields; Robert van den Hoven van Genderen; Elmar Kotter; Judy Wawira Gichoya; Tessa S Cook; Matthew B Morgan; An Tang; Nabile M Safdar; Marc Kohli
Journal:  Radiology       Date:  2019-10-01       Impact factor: 11.105

6.  Error in radiology-where are we now?

Authors:  Giles Maskell
Journal:  Br J Radiol       Date:  2018-11-28       Impact factor: 3.039

7.  11C-MET PET/MRI for detection of recurrent glioma.

Authors:  C Deuschl; J Kirchner; T D Poeppel; B Schaarschmidt; S Kebir; N El Hindy; J Hense; H H Quick; M Glas; K Herrmann; L Umutlu; C Moenninghoff; A Radbruch; M Forsting; M Schlamann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-28       Impact factor: 9.236

8.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.

Authors:  Jill S Barnholtz-Sloan; Andrew E Sloan; Faith G Davis; Fawn D Vigneau; Ping Lai; Raymond E Sawaya
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

Review 9.  Brain metastases.

Authors:  Andrew B Lassman; Lisa M DeAngelis
Journal:  Neurol Clin       Date:  2003-02       Impact factor: 3.806

Review 10.  Fatigue in radiology: a fertile area for future research.

Authors:  Sian Taylor-Phillips; Chris Stinton
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.